Protein Electrophoresis Market Scope
Electrophoresis is the process of moving charged molecules in solution by and applying an electrical field across the mixture. Electrophoresis has been extensively developed for molecular separations because molecules in an electrical field travel at different speeds depending on their charge, shape, and size. Electrophoresis is a straightforward and quick analytical technique. It is mostly used to analyse and purify big molecules like proteins and nucleic acids, but it may also be used to analyse and purify smaller charged molecules such charged sugars, amino acids, peptides, nucleotides, and simple ions. To monitor and analyse electrophoretic separations, highly sensitive detection technologies have been devised. The increase in the prevalence of chronic diseases such as cancer is driving the growth of the worldwide protein electrophoresis market. Protein electrophoresis tests are used to detect aberrant substances known as M proteins, whose presence indicates the presence of myeloma or multiple myeloma malignancy, which has boosted the need for protein electrophoresis tests in the diagnostics industry.
The Protein Electrophoresis market study is segmented, by Application (Research, Process Validation, Diagnostics, Quality Control and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Protein Electrophoresis market throughout the predicted period.
Bio-Rad Laboratories (United States), GE Healthcare (United States), Bioptic Inc. (Taiwan), Lonza Group Ltd. (Switzerland), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Merck Millipore (United States), Agilent Technologies (United States), QIAGEN N.V. (Germany) and PerkinElmer, Inc. (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
AMA Research has segmented the market of Global Protein Electrophoresis market by Type, Application and Region.
On the basis of geography, the market of Protein Electrophoresis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On 30th June 2021 - Sebia Acquired Orgentec Diagnostika (Leading Clinical Protein Electrophoresis Equipment and Reagents Provider). The Cutting-Edge Diagnostic Company Will Provide Development Prospects and Extend Sebia's Expertise in Autoimmune, Infectious Diseases, And Clinical Trials Serving Wider Range of Clients.
On 1st September 2021 - Sciex Launched BioPhase 8800 for High-Throughput Capillary Electrophoresis. BioPhase 8800 Allows for High-Throughput, Sensitive CE-SDS and Capillary Isoelectric-Focusing Examination of Huge Sample Sets. The System May be Utilised for Bioprocessing, Analytical Development, And Quality Analysis/Quality Control Applications.
Market Trend
- Rising Geriatric Population
Market Drivers
- Prevalence of Chronic Diseases
- High Investment in Healthcare R&D
Opportunities
- Growth in Healthcare Infrastructure Across Emerging Regions
Restraints
Challenges
- Lack of Skilled Professionals
Key Target Audience
Protein Electrophoresis Solution Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others